nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP2D6—Hydroxyurea—head and neck cancer	0.319	0.378	CbGbCtD
Rimonabant—CYP1A2—Fluorouracil—head and neck cancer	0.148	0.175	CbGbCtD
Rimonabant—CYP2C9—Fluorouracil—head and neck cancer	0.133	0.158	CbGbCtD
Rimonabant—CYP2D6—Vinblastine—head and neck cancer	0.113	0.134	CbGbCtD
Rimonabant—CYP3A4—Vinblastine—head and neck cancer	0.0717	0.0851	CbGbCtD
Rimonabant—CYP3A4—Docetaxel—head and neck cancer	0.0591	0.0701	CbGbCtD
Rimonabant—Memory loss—Fluorouracil—head and neck cancer	0.0073	0.0865	CcSEcCtD
Rimonabant—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00409	0.0563	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00188	0.0258	CbGpPWpGaD
Rimonabant—Depression—Vinblastine—head and neck cancer	0.00182	0.0216	CcSEcCtD
Rimonabant—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00179	0.0246	CbGpPWpGaD
Rimonabant—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00178	0.0245	CbGpPWpGaD
Rimonabant—Infestation NOS—Hydroxyurea—head and neck cancer	0.00167	0.0198	CcSEcCtD
Rimonabant—Infestation—Hydroxyurea—head and neck cancer	0.00167	0.0198	CcSEcCtD
Rimonabant—Amnesia—Fluorouracil—head and neck cancer	0.00166	0.0196	CcSEcCtD
Rimonabant—Hypoaesthesia—Vinblastine—head and neck cancer	0.00163	0.0193	CcSEcCtD
Rimonabant—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00162	0.0223	CbGpPWpGaD
Rimonabant—Lethargy—Fluorouracil—head and neck cancer	0.00159	0.0188	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00155	0.0213	CbGpPWpGaD
Rimonabant—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00152	0.021	CbGpPWpGaD
Rimonabant—Hallucination—Hydroxyurea—head and neck cancer	0.00149	0.0176	CcSEcCtD
Rimonabant—Irritability—Fluorouracil—head and neck cancer	0.00149	0.0176	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00147	0.0203	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—KISS1—head and neck cancer	0.00143	0.0197	CbGpPWpGaD
Rimonabant—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00138	0.0191	CbGpPWpGaD
Rimonabant—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00138	0.019	CbGpPWpGaD
Rimonabant—Angiopathy—Hydroxyurea—head and neck cancer	0.00136	0.0161	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00125	0.0148	CcSEcCtD
Rimonabant—Convulsion—Vinblastine—head and neck cancer	0.00124	0.0147	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00121	0.0167	CbGpPWpGaD
Rimonabant—CNR1—N-cadherin signaling events—PIK3CA—head and neck cancer	0.00121	0.0167	CbGpPWpGaD
Rimonabant—Hot flush—Docetaxel—head and neck cancer	0.0012	0.0142	CcSEcCtD
Rimonabant—Infestation NOS—Fluorouracil—head and neck cancer	0.0012	0.0142	CcSEcCtD
Rimonabant—Infestation—Fluorouracil—head and neck cancer	0.0012	0.0142	CcSEcCtD
Rimonabant—Menopausal symptoms—Docetaxel—head and neck cancer	0.00119	0.0141	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—GRP—head and neck cancer	0.00118	0.0162	CbGpPWpGaD
Rimonabant—Lethargy—Docetaxel—head and neck cancer	0.00115	0.0136	CcSEcCtD
Rimonabant—Convulsion—Hydroxyurea—head and neck cancer	0.00113	0.0134	CcSEcCtD
Rimonabant—Sinusitis—Fluorouracil—head and neck cancer	0.00113	0.0133	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—KISS1—head and neck cancer	0.00112	0.0154	CbGpPWpGaD
Rimonabant—Anorexia—Vinblastine—head and neck cancer	0.00111	0.0132	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0011	0.0131	CcSEcCtD
Rimonabant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00109	0.0151	CbGpPWpGaD
Rimonabant—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00107	0.0127	CcSEcCtD
Rimonabant—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00107	0.0147	CbGpPWpGaD
Rimonabant—Infection—Hydroxyurea—head and neck cancer	0.00106	0.0125	CcSEcCtD
Rimonabant—Paraesthesia—Vinblastine—head and neck cancer	0.00105	0.0124	CcSEcCtD
Rimonabant—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00104	0.0124	CcSEcCtD
Rimonabant—Skin disorder—Hydroxyurea—head and neck cancer	0.00103	0.0122	CcSEcCtD
Rimonabant—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.00103	0.0142	CbGpPWpGaD
Rimonabant—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00103	0.0142	CbGpPWpGaD
Rimonabant—Anorexia—Hydroxyurea—head and neck cancer	0.00101	0.012	CcSEcCtD
Rimonabant—Decreased appetite—Vinblastine—head and neck cancer	0.00101	0.012	CcSEcCtD
Rimonabant—Cramp muscle—Docetaxel—head and neck cancer	0.00101	0.012	CcSEcCtD
Rimonabant—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000954	0.0113	CcSEcCtD
Rimonabant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000934	0.0129	CbGpPWpGaD
Rimonabant—Decreased appetite—Hydroxyurea—head and neck cancer	0.000925	0.011	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—GRP—head and neck cancer	0.000924	0.0127	CbGpPWpGaD
Rimonabant—Abdominal pain—Vinblastine—head and neck cancer	0.000922	0.0109	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000918	0.0109	CcSEcCtD
Rimonabant—Fatigue—Hydroxyurea—head and neck cancer	0.000917	0.0109	CcSEcCtD
Rimonabant—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000874	0.012	CbGpPWpGaD
Rimonabant—Infestation—Docetaxel—head and neck cancer	0.000866	0.0103	CcSEcCtD
Rimonabant—Infestation NOS—Docetaxel—head and neck cancer	0.000866	0.0103	CcSEcCtD
Rimonabant—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000863	0.0119	CbGpPWpGaD
Rimonabant—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000856	0.0118	CbGpPWpGaD
Rimonabant—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000839	0.0116	CbGpPWpGaD
Rimonabant—Asthenia—Vinblastine—head and neck cancer	0.000837	0.00991	CcSEcCtD
Rimonabant—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00083	0.0114	CbGpPWpGaD
Rimonabant—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000823	0.0113	CbGpPWpGaD
Rimonabant—Convulsion—Fluorouracil—head and neck cancer	0.000813	0.00963	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—KISS1—head and neck cancer	0.000808	0.0111	CbGpPWpGaD
Rimonabant—Diarrhoea—Vinblastine—head and neck cancer	0.000798	0.00945	CcSEcCtD
Rimonabant—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000795	0.011	CbGpPWpGaD
Rimonabant—Hypoaesthesia—Docetaxel—head and neck cancer	0.000774	0.00917	CcSEcCtD
Rimonabant—Dizziness—Vinblastine—head and neck cancer	0.000771	0.00913	CcSEcCtD
Rimonabant—Connective tissue disorder—Docetaxel—head and neck cancer	0.000764	0.00905	CcSEcCtD
Rimonabant—Asthenia—Hydroxyurea—head and neck cancer	0.000763	0.00904	CcSEcCtD
Rimonabant—Infection—Fluorouracil—head and neck cancer	0.000761	0.00901	CcSEcCtD
Rimonabant—Nervous system disorder—Fluorouracil—head and neck cancer	0.000751	0.00889	CcSEcCtD
Rimonabant—Vomiting—Vinblastine—head and neck cancer	0.000742	0.00878	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—KISS1—head and neck cancer	0.000734	0.0101	CbGpPWpGaD
Rimonabant—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000731	0.0101	CbGpPWpGaD
Rimonabant—Headache—Vinblastine—head and neck cancer	0.000731	0.00865	CcSEcCtD
Rimonabant—Anorexia—Fluorouracil—head and neck cancer	0.00073	0.00864	CcSEcCtD
Rimonabant—Diarrhoea—Hydroxyurea—head and neck cancer	0.000728	0.00862	CcSEcCtD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000721	0.00993	CbGpPWpGaD
Rimonabant—Angiopathy—Docetaxel—head and neck cancer	0.000706	0.00836	CcSEcCtD
Rimonabant—Dizziness—Hydroxyurea—head and neck cancer	0.000703	0.00833	CcSEcCtD
Rimonabant—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000703	0.00968	CbGpPWpGaD
Rimonabant—Mediastinal disorder—Docetaxel—head and neck cancer	0.000701	0.0083	CcSEcCtD
Rimonabant—Nausea—Vinblastine—head and neck cancer	0.000693	0.00821	CcSEcCtD
Rimonabant—Insomnia—Fluorouracil—head and neck cancer	0.000692	0.0082	CcSEcCtD
Rimonabant—Paraesthesia—Fluorouracil—head and neck cancer	0.000687	0.00814	CcSEcCtD
Rimonabant—Mental disorder—Docetaxel—head and neck cancer	0.000681	0.00807	CcSEcCtD
Rimonabant—Malnutrition—Docetaxel—head and neck cancer	0.000677	0.00802	CcSEcCtD
Rimonabant—Vomiting—Hydroxyurea—head and neck cancer	0.000676	0.00801	CcSEcCtD
Rimonabant—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000675	0.00929	CbGpPWpGaD
Rimonabant—Rash—Hydroxyurea—head and neck cancer	0.000671	0.00794	CcSEcCtD
Rimonabant—Dermatitis—Hydroxyurea—head and neck cancer	0.00067	0.00794	CcSEcCtD
Rimonabant—Headache—Hydroxyurea—head and neck cancer	0.000666	0.00789	CcSEcCtD
Rimonabant—Decreased appetite—Fluorouracil—head and neck cancer	0.000666	0.00788	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—GRP—head and neck cancer	0.000665	0.00916	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000661	0.00783	CcSEcCtD
Rimonabant—Muscle spasms—Docetaxel—head and neck cancer	0.000651	0.00771	CcSEcCtD
Rimonabant—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000648	0.00892	CbGpPWpGaD
Rimonabant—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000641	0.00883	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—KISS1—head and neck cancer	0.000634	0.00873	CbGpPWpGaD
Rimonabant—Nausea—Hydroxyurea—head and neck cancer	0.000632	0.00748	CcSEcCtD
Rimonabant—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000614	0.00845	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—GRP—head and neck cancer	0.000604	0.00832	CbGpPWpGaD
Rimonabant—Convulsion—Docetaxel—head and neck cancer	0.000587	0.00695	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—KISS1—head and neck cancer	0.000576	0.00793	CbGpPWpGaD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000572	0.00678	CcSEcCtD
Rimonabant—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000564	0.00777	CbGpPWpGaD
Rimonabant—Dry mouth—Docetaxel—head and neck cancer	0.000564	0.00668	CcSEcCtD
Rimonabant—Infection—Docetaxel—head and neck cancer	0.000549	0.0065	CcSEcCtD
Rimonabant—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000543	0.00748	CbGpPWpGaD
Rimonabant—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000543	0.00747	CbGpPWpGaD
Rimonabant—Nervous system disorder—Docetaxel—head and neck cancer	0.000542	0.00642	CcSEcCtD
Rimonabant—Pruritus—Fluorouracil—head and neck cancer	0.000542	0.00642	CcSEcCtD
Rimonabant—Skin disorder—Docetaxel—head and neck cancer	0.000537	0.00636	CcSEcCtD
Rimonabant—Anorexia—Docetaxel—head and neck cancer	0.000527	0.00624	CcSEcCtD
Rimonabant—Diarrhoea—Fluorouracil—head and neck cancer	0.000524	0.0062	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—GRP—head and neck cancer	0.000522	0.00719	CbGpPWpGaD
Rimonabant—Dizziness—Fluorouracil—head and neck cancer	0.000506	0.006	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—STAT3—head and neck cancer	0.000506	0.00697	CbGpPWpGaD
Rimonabant—Insomnia—Docetaxel—head and neck cancer	0.0005	0.00592	CcSEcCtD
Rimonabant—Paraesthesia—Docetaxel—head and neck cancer	0.000496	0.00588	CcSEcCtD
Rimonabant—Vomiting—Fluorouracil—head and neck cancer	0.000487	0.00577	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—MAPK3—head and neck cancer	0.000484	0.00666	CbGpPWpGaD
Rimonabant—Rash—Fluorouracil—head and neck cancer	0.000483	0.00572	CcSEcCtD
Rimonabant—Dermatitis—Fluorouracil—head and neck cancer	0.000482	0.00571	CcSEcCtD
Rimonabant—Decreased appetite—Docetaxel—head and neck cancer	0.00048	0.00569	CcSEcCtD
Rimonabant—Headache—Fluorouracil—head and neck cancer	0.00048	0.00568	CcSEcCtD
Rimonabant—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000479	0.00659	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000477	0.00657	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000477	0.00565	CcSEcCtD
Rimonabant—Fatigue—Docetaxel—head and neck cancer	0.000476	0.00564	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—GRP—head and neck cancer	0.000474	0.00653	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—MAPK1—head and neck cancer	0.00046	0.00634	CbGpPWpGaD
Rimonabant—Nausea—Fluorouracil—head and neck cancer	0.000455	0.00539	CcSEcCtD
Rimonabant—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000452	0.00535	CcSEcCtD
Rimonabant—Abdominal pain—Docetaxel—head and neck cancer	0.000437	0.00517	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—KISS1—head and neck cancer	0.000433	0.00597	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000415	0.00572	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000411	0.00566	CbGpPWpGaD
Rimonabant—Asthenia—Docetaxel—head and neck cancer	0.000396	0.0047	CcSEcCtD
Rimonabant—Pruritus—Docetaxel—head and neck cancer	0.000391	0.00463	CcSEcCtD
Rimonabant—Diarrhoea—Docetaxel—head and neck cancer	0.000378	0.00448	CcSEcCtD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000375	0.00517	CbGpPWpGaD
Rimonabant—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000375	0.00517	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000375	0.00517	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—HRAS—head and neck cancer	0.000369	0.00509	CbGpPWpGaD
Rimonabant—Dizziness—Docetaxel—head and neck cancer	0.000365	0.00433	CcSEcCtD
Rimonabant—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000358	0.00493	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—GRP—head and neck cancer	0.000357	0.00491	CbGpPWpGaD
Rimonabant—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000355	0.00489	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000355	0.00489	CbGpPWpGaD
Rimonabant—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000354	0.00487	CbGpPWpGaD
Rimonabant—Vomiting—Docetaxel—head and neck cancer	0.000351	0.00416	CcSEcCtD
Rimonabant—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000351	0.00484	CbGpPWpGaD
Rimonabant—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000351	0.00483	CbGpPWpGaD
Rimonabant—Rash—Docetaxel—head and neck cancer	0.000348	0.00413	CcSEcCtD
Rimonabant—Dermatitis—Docetaxel—head and neck cancer	0.000348	0.00412	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—STAT6—head and neck cancer	0.000346	0.00477	CbGpPWpGaD
Rimonabant—Headache—Docetaxel—head and neck cancer	0.000346	0.0041	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—KISS1—head and neck cancer	0.00034	0.00468	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.00033	0.00454	CbGpPWpGaD
Rimonabant—Nausea—Docetaxel—head and neck cancer	0.000328	0.00389	CcSEcCtD
Rimonabant—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000327	0.0045	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—AKT1—head and neck cancer	0.000326	0.00449	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000325	0.00448	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000322	0.00444	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—YAP1—head and neck cancer	0.000307	0.00422	CbGpPWpGaD
Rimonabant—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000304	0.00418	CbGpPWpGaD
Rimonabant—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.0003	0.00413	CbGpPWpGaD
Rimonabant—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000291	0.004	CbGpPWpGaD
Rimonabant—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00029	0.00399	CbGpPWpGaD
Rimonabant—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000288	0.00397	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GRP—head and neck cancer	0.00028	0.00386	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000279	0.00384	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000275	0.00379	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STAT6—head and neck cancer	0.000272	0.00374	CbGpPWpGaD
Rimonabant—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000246	0.00339	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000244	0.00337	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—YAP1—head and neck cancer	0.000241	0.00331	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000236	0.00325	CbGpPWpGaD
Rimonabant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000234	0.00323	CbGpPWpGaD
Rimonabant—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000231	0.00318	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000223	0.00307	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000215	0.00297	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000213	0.00293	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000209	0.00288	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000207	0.00285	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00019	0.00262	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—IL2—head and neck cancer	0.000177	0.00244	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000176	0.00242	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000163	0.00224	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000161	0.00222	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL2—head and neck cancer	0.000161	0.00222	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000161	0.00221	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000159	0.00219	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000158	0.00218	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000158	0.00218	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000158	0.00218	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000154	0.00212	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000153	0.00211	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000152	0.0021	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000151	0.00208	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—IL2—head and neck cancer	0.000139	0.00192	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOTCH1—head and neck cancer	0.000138	0.0019	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000138	0.0019	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000136	0.00187	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—UROD—head and neck cancer	0.000136	0.00187	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—UROD—head and neck cancer	0.000135	0.00185	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000131	0.0018	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—MAPK3—head and neck cancer	0.000129	0.00178	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000129	0.00178	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000127	0.00175	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL2—head and neck cancer	0.000126	0.00174	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—MAPK1—head and neck cancer	0.000123	0.0017	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—EGFR—head and neck cancer	0.000123	0.0017	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000118	0.00162	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—UROD—head and neck cancer	0.000115	0.00158	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000108	0.00149	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PIK3CA—head and neck cancer	0.000107	0.00147	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000106	0.00147	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000105	0.00145	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000104	0.00144	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—MAPK3—head and neck cancer	0.000102	0.0014	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000101	0.00139	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	9.95e-05	0.00137	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—HRAS—head and neck cancer	9.89e-05	0.00136	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—MAPK1—head and neck cancer	9.66e-05	0.00133	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EGFR—head and neck cancer	9.66e-05	0.00133	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—AKT1—head and neck cancer	9.61e-05	0.00132	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL2—head and neck cancer	9.51e-05	0.00131	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCND1—head and neck cancer	9.27e-05	0.00128	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CA—head and neck cancer	9.23e-05	0.00127	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTEN—head and neck cancer	8.95e-05	0.00123	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.92e-05	0.00123	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—UROD—head and neck cancer	8.87e-05	0.00122	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—AKT1—head and neck cancer	8.73e-05	0.0012	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CA—head and neck cancer	8.39e-05	0.00115	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VEGFA—head and neck cancer	8.08e-05	0.00111	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—STAT3—head and neck cancer	8e-05	0.0011	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—HRAS—head and neck cancer	7.76e-05	0.00107	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAPK3—head and neck cancer	7.65e-05	0.00105	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AKT1—head and neck cancer	7.54e-05	0.00104	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL2—head and neck cancer	7.46e-05	0.00103	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCND1—head and neck cancer	7.27e-05	0.001	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAPK1—head and neck cancer	7.27e-05	0.001	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGFR—head and neck cancer	7.27e-05	0.001	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTEN—head and neck cancer	7.02e-05	0.000967	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AKT1—head and neck cancer	6.85e-05	0.000943	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—head and neck cancer	6.34e-05	0.000873	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CA—head and neck cancer	6.31e-05	0.000869	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STAT3—head and neck cancer	6.28e-05	0.000865	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—head and neck cancer	6.11e-05	0.000841	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK3—head and neck cancer	6e-05	0.000826	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.93e-05	0.000817	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.87e-05	0.000809	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HRAS—head and neck cancer	5.84e-05	0.000804	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK1—head and neck cancer	5.71e-05	0.000786	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGFR—head and neck cancer	5.71e-05	0.000786	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NAT2—head and neck cancer	5.64e-05	0.000776	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NAT2—head and neck cancer	5.59e-05	0.000769	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AKT1—head and neck cancer	5.16e-05	0.00071	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.07e-05	0.000698	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.02e-05	0.000691	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CA—head and neck cancer	4.95e-05	0.000682	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—DPYD—head and neck cancer	4.94e-05	0.000681	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—DPYD—head and neck cancer	4.9e-05	0.000675	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—head and neck cancer	4.79e-05	0.00066	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NAT2—head and neck cancer	4.78e-05	0.000657	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—YAP1—head and neck cancer	4.69e-05	0.000646	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—YAP1—head and neck cancer	4.65e-05	0.00064	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HRAS—head and neck cancer	4.58e-05	0.000631	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—DPYD—head and neck cancer	4.19e-05	0.000577	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT1—head and neck cancer	4.05e-05	0.000557	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—YAP1—head and neck cancer	3.97e-05	0.000547	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NAT2—head and neck cancer	3.69e-05	0.000507	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.49e-05	0.000481	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—DPYD—head and neck cancer	3.23e-05	0.000445	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—YAP1—head and neck cancer	3.07e-05	0.000422	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.05e-05	0.00042	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.99e-05	0.000411	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TYMS—head and neck cancer	2.82e-05	0.000388	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TYMS—head and neck cancer	2.79e-05	0.000384	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.78e-05	0.000383	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.76e-05	0.00038	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GPX1—head and neck cancer	2.67e-05	0.000367	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GPX1—head and neck cancer	2.64e-05	0.000364	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.64e-05	0.000363	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.62e-05	0.00036	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.6e-05	0.000358	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TYMS—head and neck cancer	2.39e-05	0.000329	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.36e-05	0.000325	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GPX1—head and neck cancer	2.26e-05	0.000311	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.24e-05	0.000308	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.15e-05	0.000296	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TYMS—head and neck cancer	1.84e-05	0.000254	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.84e-05	0.000253	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.82e-05	0.000251	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPX1—head and neck cancer	1.74e-05	0.00024	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.73e-05	0.000238	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.57e-05	0.000216	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.56e-05	0.000214	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTEN—head and neck cancer	1.37e-05	0.000188	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTEN—head and neck cancer	1.36e-05	0.000187	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.33e-05	0.000183	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTEN—head and neck cancer	1.16e-05	0.00016	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.03e-05	0.000141	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CA—head and neck cancer	9.66e-06	0.000133	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CA—head and neck cancer	9.57e-06	0.000132	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTEN—head and neck cancer	8.95e-06	0.000123	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CA—head and neck cancer	8.18e-06	0.000113	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKT1—head and neck cancer	7.89e-06	0.000109	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKT1—head and neck cancer	7.82e-06	0.000108	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKT1—head and neck cancer	6.68e-06	9.2e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CA—head and neck cancer	6.31e-06	8.69e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKT1—head and neck cancer	5.16e-06	7.1e-05	CbGpPWpGaD
